The Hippo Pathway in Prostate Gland Homeostasis and Prostate Cancer

前列腺稳态和前列腺癌中的 Hippo 通路

基本信息

项目摘要

DESCRIPTION (provided by applicant): Chromosomal recombination resulting in a gene fusion between a strong promoter and an ETS- family transcription factor ERG is the most common genetic event in human prostate cancer. The significance of ERG overexpression and the mechanisms of ERG are not well understood. This application aims at answering these questions and builds on extensive preliminary evidence generated in our laboratory. We generated transgenic mice overexpressing ERG in mouse prostate epithelium at the levels similar to the levels of ERG in human prostate cancer, and found that these animals develop age-related prostate cancer. This is exciting, because age is the most significant factor in development of human prostate cancer. The analyses of ERG transgenic animals revealed specific activation of the genes negatively controlled by the Hippo signaling pathway. Hippo pathway is known to restrict self-renewal of stem and progenitor cells and constitutive inactivation of the Hippo pathway is causally involved in cancer in liver, skin, intestine and breast epithelium. The significance of the Hippo pathway in prostate epithelium and prostate cancer is presently unknown. We confirmed ERG-dependent activation of Hippo genes in human prostate epithelial cells and found that ERG binds to Hippo transcriptional co-activators YAP1/TAZ and potentiates their transcriptional activity. Thus, the central hypothesis of this application is that the Hippo pathway plays an important role in regulation of homeostasis of normal prostate gland and activation of Hippo target genes is the primary pathway responsible for oncogenic function of ERG in prostate cancer. We propose to comprehensively investigate this hypothesis using in vitro and in vivo approaches. In aim 1, we will investigate the physical and functional connection between ERG and YAP1/TAZ proteins. In aim 2, we will determine the mechanisms and the impact of ERG on the transcriptional output of the Hippo pathway. In aim 3, we will use genetically engineered mice to reveal the significance of the Hippo pathway in normal prostate gland homeostasis and ERG- mediated prostate cancer. Overall, this study will determine the role of the Hippo pathway in normal prostate and reveal the pivotal mechanisms responsible for the development of prostate cancer.
描述(由申请人提供):染色体重组导致强启动子和ETS家族转录因子ERG之间的基因融合是人类前列腺癌中最常见的遗传事件。ERG过表达的意义及其作用机制尚不清楚。本应用程序旨在回答这些问题,并建立在我们实验室产生的广泛初步证据的基础上。我们在小鼠前列腺上皮中产生过表达ERG的转基因小鼠,其水平与人类前列腺癌中ERG的水平相似,并发现这些动物会发生与年龄相关的前列腺癌。这是令人兴奋的,因为年龄是人类前列腺癌发展的最重要因素。对ERG转基因动物的分析表明,Hippo信号通路负调控基因的特异性激活。已知Hippo通路限制干细胞和祖细胞的自我更新,Hippo通路的组成性失活与肝脏、皮肤、肠和乳腺上皮的癌症有因果关系。Hippo通路在前列腺上皮和前列腺癌中的意义目前尚不清楚。我们证实了人类前列腺上皮细胞中Hippo基因的ERG依赖性激活,并发现ERG与Hippo转录共激活因子YAP1/TAZ结合并增强其转录活性。因此,本研究的中心假设是Hippo通路在正常前列腺的稳态调节中发挥重要作用,而Hippo靶基因的激活是ERG在前列腺癌中起致癌作用的主要途径。我们建议用体外和体内方法全面研究这一假设。在目标1中,我们将研究ERG和YAP1/TAZ蛋白之间的物理和功能联系。在目标2中,我们将确定ERG对Hippo通路转录输出的机制和影响。在目标3中,我们将使用基因工程小鼠来揭示Hippo通路在正常前列腺稳态和ERG介导的前列腺癌中的意义。总之,本研究将确定Hippo通路在正常前列腺中的作用,揭示前列腺癌发展的关键机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VALERI VASIOUKHIN其他文献

VALERI VASIOUKHIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VALERI VASIOUKHIN', 18)}}的其他基金

Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer
正常组织稳态和癌症中的基底细胞极性蛋白
  • 批准号:
    10406262
  • 财政年份:
    2019
  • 资助金额:
    $ 36.21万
  • 项目类别:
Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer
正常组织稳态和癌症中的基底细胞极性蛋白
  • 批准号:
    10667590
  • 财政年份:
    2019
  • 资助金额:
    $ 36.21万
  • 项目类别:
Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer
正常组织稳态和癌症中的基底细胞极性蛋白
  • 批准号:
    9814413
  • 财政年份:
    2019
  • 资助金额:
    $ 36.21万
  • 项目类别:
Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer
正常组织稳态和癌症中的基底细胞极性蛋白
  • 批准号:
    10601295
  • 财政年份:
    2019
  • 资助金额:
    $ 36.21万
  • 项目类别:
Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer
正常组织稳态和癌症中的基底细胞极性蛋白
  • 批准号:
    10158454
  • 财政年份:
    2019
  • 资助金额:
    $ 36.21万
  • 项目类别:
Alpha-Catenin in Regulation of Tissue Homeostasis and Cancer
α-连环蛋白调节组织稳态和癌症
  • 批准号:
    8643463
  • 财政年份:
    2014
  • 资助金额:
    $ 36.21万
  • 项目类别:
Alpha-Catenin in Regulation of Tissue Homeostasis and Cancer
α-连环蛋白调节组织稳态和癌症
  • 批准号:
    9057992
  • 财政年份:
    2014
  • 资助金额:
    $ 36.21万
  • 项目类别:
Regulation of Hippo Signaling by Src-Family Kinases
Src 家族激酶对 Hippo 信号传导的调节
  • 批准号:
    8764489
  • 财政年份:
    2014
  • 资助金额:
    $ 36.21万
  • 项目类别:
The Hippo Pathway in Prostate Gland Homeostasis and Prostate Cancer
前列腺稳态和前列腺癌中的 Hippo 通路
  • 批准号:
    9228337
  • 财政年份:
    2013
  • 资助金额:
    $ 36.21万
  • 项目类别:
The Hippo Pathway in Prostate Gland Homeostasis and Prostate Cancer
前列腺稳态和前列腺癌中的 Hippo 通路
  • 批准号:
    8517420
  • 财政年份:
    2013
  • 资助金额:
    $ 36.21万
  • 项目类别:

相似海外基金

Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
  • 批准号:
    2348998
  • 财政年份:
    2025
  • 资助金额:
    $ 36.21万
  • 项目类别:
    Standard Grant
Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
  • 批准号:
    2348999
  • 财政年份:
    2025
  • 资助金额:
    $ 36.21万
  • 项目类别:
    Standard Grant
Understanding Latin American Challenges in the 21st Century (LAC-EU)
了解拉丁美洲在 21 世纪面临的挑战 (LAC-EU)
  • 批准号:
    EP/Y034694/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.21万
  • 项目类别:
    Research Grant
Conference: North American High Order Methods Con (NAHOMCon)
会议:北美高阶方法大会 (NAHOMCon)
  • 批准号:
    2333724
  • 财政年份:
    2024
  • 资助金额:
    $ 36.21万
  • 项目类别:
    Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
  • 批准号:
    2346565
  • 财政年份:
    2024
  • 资助金额:
    $ 36.21万
  • 项目类别:
    Standard Grant
REU Site: Research Experiences for American Leadership of Industry with Zero Emissions by 2050 (REALIZE-2050)
REU 网站:2050 年美国零排放工业领先地位的研究经验 (REALIZE-2050)
  • 批准号:
    2349580
  • 财政年份:
    2024
  • 资助金额:
    $ 36.21万
  • 项目类别:
    Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
  • 批准号:
    2346564
  • 财政年份:
    2024
  • 资助金额:
    $ 36.21万
  • 项目类别:
    Standard Grant
Conference: Latin American School of Algebraic Geometry
会议:拉丁美洲代数几何学院
  • 批准号:
    2401164
  • 财政年份:
    2024
  • 资助金额:
    $ 36.21万
  • 项目类别:
    Standard Grant
Collaborative Research: Ionospheric Density Response to American Solar Eclipses Using Coordinated Radio Observations with Modeling Support
合作研究:利用协调射电观测和建模支持对美国日食的电离层密度响应
  • 批准号:
    2412294
  • 财政年份:
    2024
  • 资助金额:
    $ 36.21万
  • 项目类别:
    Standard Grant
Conference: Doctoral Consortium at Student Research Workshop at the Annual Conference of the North American Chapter of the Association for Computational Linguistics (NAACL)
会议:计算语言学协会 (NAACL) 北美分会年会学生研究研讨会上的博士联盟
  • 批准号:
    2415059
  • 财政年份:
    2024
  • 资助金额:
    $ 36.21万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了